Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

NCT01270711 · clinicaltrials.gov ↗

COMPLETED

Status

22014

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease
Hyperprolactinemia

Interventions

DRUG: Study Drug

Sponsor

Pfizer